References

1. Lomazzi, M.; Moore, M.; Johnson, A.; Balasegaram, M.; Borisch, B. Antimicrobial resistance—Moving forward? BMC Public Health 2019, 19.
2. Prestinaci, F.; Pezzotti, P.; Pantosti, A. Antimicrobial resistance: A global multifaceted phenomenon. Pathog. Glob. Health 2015, 109, 309–318.
3. Miranda, C.D.; Godoy, F.A.; Lee, M.R. Current Status of the Use of Antibiotics and the Antimicrobial Resistance in the Chilean Salmon Farms. Front. Microbiol. 2018, 9, 1284.
4. Van, T.T.H.; Yidana, Z.; Smooker, P.M.; Coloe, P.J. Antibiotic use in food animals worldwide, with a focus on Africa: Pluses and minuses. J. Glob. Antimicrob. Resist. 2020, 20, 170–177.
5. Ma, F.; Xu, S.; Tang, Z.; Li, Z.; Zhang, L. Use of antimicrobials in food animals and impact of transmission of antimicrobial resistance on humans. Biosaf. Health 2021, 3, 32–38.
6. Jasovský, D.; Littmann, J.; Zorzet, A.; Cars, O. Antimicrobial resistance—A threat to the world’s sustainable development. Upsala J. Med. Sci. 2016, 121, 159–164.
7. Nelson, R.E.; Slayton, R.B.; Stevens, V.W.; Jones, M.M.; Khader, K.; Rubin, M.A.; Jernigan, J.A.; Samore, M.H. Attributable Mortality of Healthcare-Associated Infections Due to Multidrug-Resistant Gram-Negative Bacteria and Methicillin-Resistant Staphylococcus Aureus. Infect. Control. Hosp. Epidemiol. 2017, 38, 848–856.
8. Ademe, M.; Girma, F. Candida auris: From Multidrug Resistance to Pan-Resistant Strains. Infect. Drug Resist. 2020, ume 13, 1287–1294.
9. Kampf, G.; Todt, D.; Pfaender, S.; Steinmann, E. Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents. J. Hosp. Infect. 2020, 104, 246–251.
10. Donaghy, J.A.; Jagadeesan, B.; Goodburn, K.; Grunwald, L.; Jensen, O.N.; Jespers, A.D.; Kanagachandran, K.; Lafforgue, H.; Seefelder, W.; Quentin, M.C. Relationship of Sanitizers, Disinfectants, and Cleaning Agents with Antimicrobial Resistance. J. Food Prot. 2019, 82, 889–902.
11. Kahrs, R.F. General disinfection guidelines. Rev. Sci. Tech. 1995, 14, 105–163.
12. Rutala, W.A.; Weber, D.J. Disinfection and Sterilization in Health Care Facilities: What Clinicians Need to Know. Clin. Infect. Dis. 2004, 39, 702–709.
13. Lin, Q.; Lim, J.Y.C.; Xue, K.; Yew, P.Y.M.; Owh, C.; Chee, P.L.; Loh, X.J. Sanitizing agents for virus inactivation and disinfection. View 2020, 1.
14. Guan, J.; Chan, M.; Brooks, B.W.; Rohonczy, L. Influence of temperature and organic load on chemical disinfection of Geobacillus steareothermophilus spores, a surrogate for Bacillus anthracis. Can. J. Vet. Res. 2013, 77, 100–104.
15. Kumar, G.D.; Mishra, A.; Dunn, L.; Townsend, A.; Oguadinma, I.C.; Bright, K.R.; Gerba, C.P. Biocides and Novel Antimicrobial Agents for the Mitigation of Coronaviruses. Front. Microbiol. 2020, 11, 1351.
16. Bock, L.J. Bacterial biocide resistance: A new scourge of the infectious disease world? Arch. Dis. Child. 2019, 104, 1029–1033.
17. Wand, M.E. Bacterial Resistance to Hospital Disinfection. In Modeling the Transmission and Prevention of Infectious Disease; Hurst, C.J., Ed.; Springer: Berlin/Heidelberg, Germany, 2017; pp. 19–54.
18. Maillard, J.Y. Antimicrobial biocides in the healthcare environment: Efficacy, usage, policies, and perceived problems. Ther. Clin. Risk Manag. 2005, 1, 307–320.
19. Holah, J.T. Cleaning and disinfection practices in food processing. In Hygiene in Food Processing, Principles and Practice; Woodhead Publishing Limited: Cambridge, UK, 2014; pp. 259–304.
20. Maillard, J.-Y. Resistance of Bacteria to Biocides. Microbiol. Spectr. 2018, 6.
21. De Oliveira, D.M.P.; Forde, B.M.; Kidd, T.J.; Harris, P.N.A.; Schembri, M.A.; Beatson, S.A.; Paterson, D.L.; Walker, M.J. Antimicrobial Resistance in ESKAPE Pathogens. Clin. Microbiol. Rev. 2020, 33.
22. Vijayakumar, R.; Sandle, T. A review on biocide reduced susceptibility due to plasmid-borne antiseptic-resistant genes—special notes on pharmaceutical environmental isolates. J. Appl. Microbiol. 2019, 126, 1011–1022.
23. Mima, T.; Joshi, S.; Gomez-Escalada, M.; Schweizer, H.P. Identification and Characterization of TriABC-OpmH, a Triclosan Efflux Pump of Pseudomonas aeruginosa Requiring Two Membrane Fusion Proteins. J. Bacteriol. 2007, 189, 7600–7609.
24. Liu, Q.; Zhao, H.; Han, L.; Shu, W.; Wu, Q.; Ni, Y. Frequency of biocide-resistant genes and susceptibility to chlorhexidine in high-level mupirocin-resistant, methicillin-resistant Staphylococcus aureus (MuH MRSA). Diagn. Microbiol. Infect. Dis. 2015, 82, 278–283.
25. Poole, K. Efflux-mediated antimicrobial resistance. J. Antimicrob. Chemother. 2005, 56, 20–51.
26. Pathania, R.; Sharma, A.; Gupta, V.K. Efflux pump inhibitors for bacterial pathogens: From bench to bedside. Indian J. Med. Res. 2019, 149, 129–145.
27. Piddock, L.J.V. Multidrug-resistance efflux pumps—Not just for resistance. Nat. Rev. Microbiol. 2006, 4, 629–636.
28. Cheng, G.; Ning, J.; Ahmed, S.; Huang, J.; Ullah, R.; An, B.; Hao, H.; Dai, M.; Huang, L.; Wang, X.; et al. Selection and dissemination of antimicrobial resistance in Agri-food production. Antimicrob. Resist. Infect. Control. 2019, 8, 1–13.
29. Pastrana-Carrasco, J.; Garza-Ramos, J.U.; Barrios, H.; Morfin-Otero, R.; Rodríguez-Noriega, E.; Barajas, J.M.; Suárez, S.; Díaz, R.; Miranda, G.; Solórzano, F.; et al. Gene frequency and biocide resistance in extended-spectrum beta-lactamase producing enterobacteriaceae clinical isolates. Rev. Investig. Clin. 2012, 64 Pt 1, 535–540. (In Spanish)
30. Xiao, T.; Wu, Z.; Shi, Q.; Zhang, X.; Zhou, Y.; Yu, X.; Xiao, Y. A retrospective analysis of risk factors and outcomes in patients with extended-spectrum beta-lactamase-producing Escherichia coli bloodstream infections. J. Glob. Antimicrob. Resist. 2019, 17, 147–156.
31. Cadena, M.; Kelman, T.; Marco, M.L.; Pitesky, M. Understanding antimicrobial resistance (AMR) profiles of Salmonella biofilm and planktonic bacteria challenged with disinfectants commonly used during poultry processing. Foods 2019, 87, 275.
32. Bjarnsholt, T. The role of bacterial biofilms in chronic infections. APMIS 2013, 121, 1–58.
33. Touzel, R.E.; Sutton, J.M.; Wand, M.E. Establishment of a multi-species biofilm model to evaluate chlorhexidine efficacy. J. Hosp. Infect. 2016, 92, 154–160.
34. Perumal, P.K.; Wand, M.E.; Sutton, J.M. Evaluation of the effectiveness of the hydrogenperoxide based disinfectants on biofilms formed by Gram-negative pathogens. J. Hosp. Infect. 2014, 87, 227–233.
35. Kampf, G. Antibiotic resistance can be enhanced in Gram-positive species by some biocidal agents used for disinfection. Antibiotics 2019, 8, 13.
36. Taheri, N.; Ardebili, A.; Amouzandeh-Nobaveh, A.; Ghaznavi-Rad, E. Frequency of Antiseptic Resistance Among Staphylococcus aureus and Coagulase-Negative Staphylococci Isolated from a University Hospital in Central Iran. Oman Med. J. 2016, 31, 426–432.
37. Conceição, T.; Coelho, C.; de Lencastre, H.; Aires-De-Sousa, M. High Prevalence of Biocide Resistance Determinants in Staphylococcus aureus Isolates from Three African Countries. Antimicrob. Agents Chemother. 2015, 60, 678–681.
38. Bush, K. Past and Present Perspectives on β-Lactamases. Antimicrob. Agents Chemother. 2018.
39. Slipski, C.J.; Zhanel, G.G.; Bay, D.C. Biocide selective TolC-independent efflux pumps in Enterobacteriaceae. J. Membr. Biol. 2018, 251, 15–33.
40. Li, X.-Z.; Plésiat, P.; Nikaido, H. The Challenge of Efflux-Mediated Antibiotic Resistance in Gram-Negative Bacteria. Clin. Microbiol. Rev. 2015, 28, 337–418.
41. Romero, J.L.; Grande Burgos, M.J.; Pérez-Pulido, R.; Gálvez, A.; Lucas, R. Resistance to antibiotics, biocides, preservatives and metals in bacteria isolated from seafoods: Co-selection of strains resistant or tolerant to different classes of compounds. Front. Microbiol. 2017, 8, 1650.
42. Liu, W.J.; Fu, L.; Huang, M.; Zhang, J.P.; Wu, Y.; Zhou, Y.S.; Zeng, J.; Wang, G.X. Frequency of antiseptic resistance genes and reduced susceptibility to biocides in carbapenem-resistant Acinetobacter baumannii. J. Med. Microbiol. 2017, 66, 13–17.
43. Su, X.Z.; Chen, J.; Mizushima, T.; Kuroda, T.; Tsuchiya, T. AbeM, an H+-coupled Acinetobacter baumannii multi-drug efflux pump belonging to the MATE family of transporters. Antimicrob. Agents Chemother. 2005, 49, 4362–4364.
44. Chitsaz, M.; Booth, L.; Blyth, M.T.; O’Mara, M.L.; Brown, M.H. Multidrug Resistance in Neisseria gonorrhoeae: Identification of Functionally Important Residues in the MtrD Efflux Protein. mBio 2019, 10.
45. Amsalu, A.; Sapula, S.A.; De Barros Lopes, M.; Hart, B.J.; Nguyen, A.H.; Drigo, B.; Turnidge, J.; Leong, L.E.; Venter, H. Efflux pump-driven antibiotic and biocide cross-resistance in Pseudomonas aeruginosa isolated from different ecological niches: A case study in the development of multidrug resistance in environmental hotspots. Microorganisms 2020, 8, 1647.
46. Lin, F.; Xu, Y.; Chang, Y.; Liu, C.; Jia, X.; Ling, B. Molecular Characterization of Reduced Susceptibility to Biocides in Clinical Isolates of Acinetobacter baumannii. Front. Microbiol. 2017, 8, 1836.
47. Davin-Regli, A. Enterobacter aerogenes and Enterobacter cloacae; Versatile bacterial pathogens confronting antibiotic treatment. Front. Microbiol. 2015, 6, 392.
48. Roedel, A.; Vincze, S.; Projahn, M.; Roesler, U.; Robé, C.; Hammerl, J.A.; Noll, M.; Al Dahouk, S.; Dieckmann, R. Genetic but No Phenotypic Associations between Biocide Tolerance and Antibiotic Resistance in Escherichia coli from German Broiler Fattening Farms. Microorganisms 2021, 9, 651.
49. Colclough, A.L.; Alav, I.; Whittle, E.E.; Pugh, H.L.; Darby, E.M.; Legood, S.W.; McNeil, H.E.; Blair, J.M. RND efflux pumps in Gram-negative bacteria; regulation, structure and role in antibiotic resistance. Futur. Microbiol. 2020, 15, 143–157.
50. Barabote, R.D.; Thekkiniath, J.; Strauss, R.E.; Vediyappan, G.; Fralick, J.A.; Francisco, M.J.S. Xenobiotic Efflux in Bacteria and Fungi: A Genomics Update. Adv. Enzymol. Relat. Areas Mol. Biol. 2011, 77, 237–306.
51. Brown, G.D.; Denning, D.W.; Gow, N.A.; Levitz, S.M.; Netea, M.G.; White, T.C. Hidden killers: Human fungal infections. Sci. Transl. Med. 2012, 4, rv113.
52. Meade, E.; Savage, M.; Slattery, M.A.; Garvey, M. Disinfection of Mycotic Species Isolated from Cases of Bovine Mastitis Showing Antifungal Resistance. Cohesive J. Microbiol. Infect. Dis. 2020, 3.
53. Meade, E.; Savage, M.; Slattery, M.A.; Garvey, M. An Assessment of Alternative Therapeutic Options for the Treatment of Prolonged Zoonotic Fungal Infections in Companion Animals. J. Microbiol. Biotechnol. 2019, 4, 000149.
54. Kalem, M.C.; Subbiah, H.; Leipheimer, J.; Glazier, V.E.; Panepinto, J.C. Puf4 medicates post-transcriptional regulation of caspofungin resistance in Cryptococcus neoformans. bioRxiv 2020.
55. Cowen, L.E.; Sanglard, D.; Howard, S.J.; Rogers, P.D.; Perlin, D.S. Mechanisms of Antifungal Drug Resistance. Cold Spring Harb. Perspect. Med. 2015, 5, a019752.
56. Eissa, M.E.; El Naby, M.A.; Beshir, M.M. Bacterial vs. fungal spore resistance to peroxygen biocide on inanimate surfaces. Bull. Fac. Pharm. Cairo Univ. 2014, 52, 219–224.
57. Rogers, B.D.A.; Kolaczkowski, M.; Carvajal, E.; Balzi, E.; Goffeau, A. The pleitropic drug ABC transporters from Saccharomyces cerevisiae. J. Mol. Microbiol. Biotechnol. 2003, 3, 207–214.
58. Bhattacharya, S.; Sae-Tia, S.; Fries, B.C. Candidiasis and Mechanisms of Antifungal Resistance. Antibiotics 2020, 9, 312.
59. Sandle, T.; Vijayakumar, R.; Al Aboody, M.S.; Saravanakumar, S. In vitro fungicidal activity of biocides against pharmaceutical environmental fungal isolates. J. Appl. Microbiol. 2014, 117, 1267–1273.
60. Mihriban, K.; Yasemin, S.; Aycan, Y. The fungicidal efficacy of various commercial disinfectants used in the food industry. Ann. Microbiol. 2006, 56, 325–330.
61. Mataraci-Kara, E.; Ataman, M.; Yilmaz, G.; Ozbek-Celik, B. Evaluation of antifungal and disinfectant-resistant Candida species isolated from hospital wastewater. Arch. Microbiol. 2020, 202, 1–8.
62. Cadnum, J.L.; Shaikh, A.A.; Piedrahita, C.T.; Sankar, T.; Jencson, A.L.; Larkin, E.L.; Ghannoum, M.A.; Donskey, C.J. Effectiveness of Disinfectants Against Candida auris and other Candida Species. Infect. Control. Hosp. Epidemiol. 2017, 38, 1240–1243.
63. Moore, G.; Schelenz, S.; Borman, A.M.; Johnson, E.M.; Brown, C.S. Yeasticidal activity of chemical disinfectants and antiseptics against Candida auris. J. Hosp. Infect. 2017, 97, 371–375.
64. Ku, T.S.N.; Walraven, C.J.; Lee, S.A. Candida auris: Disinfectants and Implications for Infection Control. Front. Microbiol. 2018, 9, 726.
65. Sisti, M.; Brandi, G.; De Santi, M.; Rinaldi, L.; Schiavano, G.F. Disinfection efficacy of chlorine and peracetic acid alone or in combination against Aspergillus spp. and Candida albicans in drinking water. J. Water Health 2011, 10, 11–19.
66. Nuanualsuwan, S.; Cliver, D.O. Capsid Functions of Inactivated Human Picornaviruses and Feline Calicivirus. Appl. Environ. Microbiol. 2003, 69, 350–357.
67. Wigginton, K.R.; Pecson, B.M.; Sigstam, T.; Bosshard, F.; Kohn, T. Virus Inactivation Mechanisms: Impact of Disinfectants on Virus Function and Structural Integrity. Environ. Sci. Technol. 2012, 46, 12069–12078.
68. Mattle, M.J.; Crouzy, B.; Brennecke, M.; Wigginton, K.R.; Perona, P.; Kohn, T. Impact of Virus Aggregation on Inactivation by Peracetic Acid and Implications for Other Disinfectants. Environ. Sci. Technol. 2011, 45, 7710–7717.
69. Weber, D.J.; Rutala, W.A.; Healthcare Infection Control Practices Advisory Committee (HICPAC). Guideline for Disinfection and Sterilization in Healthcare Facilities. 2019. Available online: (accessed on 22 March 2021).
70. Ansaldi, F.; Banfi, F.; Morelli, P.; Valle, L.; Durando, P.; Sticchi, L.; Contos, S.; Gasparini, R.; Crovari, P. SARS-CoV, influenza A and syncitial respiratory virus resistance against common disinfectants and ultraviolet irradiation. J. Prev. Med. Hyg. 2004, 45, 5–8.
71. Piret, J.; Roy, S.; Gagnon, M.; Landry, S.; Désormeaux, A.; Omar, R.F.; Bergeron, M.G. Comparative Study of Mechanisms of Herpes Simplex Virus Inactivation by Sodium Lauryl Sulfate and n-Lauroylsarcosine. Antimicrob. Agents Chemother. 2002, 46, 2933–2942.
72. Al-Sayah, M.H. Chemical disinfectants of COVID-19: An overview. J. Water Health 2020, 18, 843–848.
73. Wang, X.-W.; Li, J.-S.; Jin, M.; Zhen, B.; Kong, Q.-X.; Song, N.; Xiao, W.-J.; Yin, J.; Wei, W.; Wang, G.-J.; et al. Study on the resistance of severe acute respiratory syndrome-associated coronavirus. J. Virol. Methods 2005, 126, 171–177.
74. McDonnell, G.; Russell, A.D. Antiseptics and Disinfectants: Activity, Action, and Resistance. Clin. Microbiol. Rev. 1999, 12, 147–179.
75. Bosco-Borgeat, M.E.; Mazza, M.; Taverna, C.G.; Córdoba, S.; Murisengo, O.A.; Vivot, W.; Davel, G. Amino acid substitution in Cryptococcus neoformans lanosterol 14-α-demethylase involved in fluconazole resistance in clinical isolates. Rev. Argent. Microbiol. 2016, 48, 137–142.
76. Carolus, H.; Pierson, S.; Lagrou, K.; Van Dijck, P. Amphotericin B and Other Polyenes—Discovery, Clinical Use, Mode of Action and Drug Resistance. J. Fungi 2020, 6, 321.
77. Rajendran, M.; Khaithir, T.M.N.; Santhanam, J. Determination of azole antifungal drug resistance mechanisms involving Cyp51A gene in clinical isolates of Aspergillus fumigatus and Aspergillus niger. Malays. J. Microbiol. 2016, 12, 205–210.
78. World Health Organization. HIV Drug Resistance Report 2019; Licence CC BY-NC-SA 3.0 IGO; World Health Organization: Geneva, Switzerland, 2019.
79. Hao, H.; Cheng, G.; Iqbal, Z.; Ai, X.; Hussain, H.I.; Huang, L.; Dai, M.; Wang, Y.; Liu, Z.; Yuan, Z. Benefits and risks of antimicrobial use in food-producing animals. Front. Microbiol. 2014, 5, 288.
80. Mulani, M.S.; Kamble, E.E.; Kumkar, S.N.; Tawre, M.S.; Pardesi, K.R. Emerging Strategies to Combat ESKAPE Pathogens in the Era of Antimicrobial Resistance: A Review. Front. Microbiol. 2019, 10, 539.
81. Kampf, G. Biocidal agents used for disinfection can enhance antibiotic resistance in gram-negative species. Antibiotics 2018, 7, 110.
82. Mehrad, B.; Clark, N.M.; Zhanel, G.G.; Lynch, J.P. Antimicrobial Resistance in Hospital-Acquired Gram-Negative Bacterial Infections. Chest 2015, 147, 1413–1421.
83. Kang, C.; Kim, S.; Kim, H.; Park, S.; Choe, Y.; Oh, M.; Kim, E.; Choe, K. Pseudomonas aeruginosa Bacteremia: Risk Factors for Mortality and Influence of Delayed Receipt of Effective Antimicrobial Therapy on Clinical Outcome. Clin. Infect. Dis. 2003, 37, 745–751.
84. Bhattacharya, A.; Nsonwu, O.; Johnson, A.; Hope, R. Estimating the incidence and 30-day all-cause mortality rate of Escherichia coli bacteraemia in England by 2020/21. J. Hosp. Infect. 2018, 98, 228–231.
85. Karatzas, K.A.G.; Webber, M.A.; Jorgensen, F.; Woodward, M.J.; Piddock, L.J.V.; Humphrey, T.J. Prolonged treatment of Salmonella enterica serovar Typhimurium with commercial disinfectants selects for multiple antibiotic resistance, increased efflux and reduced invasiveness. J. Antimicrob. Chemother. 2007, 60, 947–955.
86. Bougnoux, M.-E.; Brun, S.; Zahar, J.-R. Healthcare-associated fungal outbreaks: New and uncommon species, New molecular tools for investigation and prevention. Antimicrob. Resist. Infect. Control. 2018, 7, 1–9.
87. Seyedmousavi, S.; Guillot, J.; Tolooe, A.; Verweij, P.; De Hoog, G. Neglected fungal zoonoses: Hidden threats to man and animals. Clin. Microbiol. Infect. 2015, 21, 416–425.
88. Chow, E.J.; Mermel, L.A. Hospital-Acquired Respiratory Viral Infections: Incidence, Morbidity, and Mortality in Pediatric and Adult Patients. Open Forum Infect. Dis. 2017, 4, ofx006.
89. Micek, S.T.; Chew, B.; Hampton, N.; Kollef, M.H. A Case-Control Study Assessing the Impact of Nonventilated Hospital-Acquired Pneumonia on Patient Outcomes. Chest 2016, 150, 1008–1014.
90. Dumas, O.; Varraso, R.; Boggs, K.M.; Quinot, C.; Zock, J.-P.; Henneberger, P.K.; Speizer, F.E.; Le Moual, N.; Camargo, C.A., Jr. Association of occupational exposure to disinfectants with incidence of chronic obstructive pulmonary disease among US female nurses. JAMA Netw. Open 2019, 2, e1913563.
91. Nabi, G.; Wang, Y.; Hao, Y.; Khan, S.; Wu, Y.; Li, D. Massive use of disinfectants against COVID-19 poses potential risks to urban wildlife. Environ. Res. 2020, 188, 109916.